After a year defined by conviction and selectivity, healthcare M&A enters the second half of 2026 with renewed confidence and a clear focus on quality, scalability, and operational value. Dealmaking in the sector regained momentum in 1H26 as buyers grew more willing to transact despite persistent economic and regulatory uncertainty. Deal volume surged 132% year on year to USD 212.8bn across 694 transactions, marking the highest half-year total since 2021. The rebound follows a muted 1H25, when deal volume fell 20% to USD 91.6bn. The recovery has remained highly selective, with buyers concentrating capital in quality, scaled platforms with clean earnings and sustainable growth.
Read the full article: Healthcare M&A Regains Momentum as Buyers Remain Selective //
Source: https://ionanalytics.com/insights/mergermarket/healthcare-ma-regains-momentum-as-buyers-remain-selective/